First Time Loading...

Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390

Watchlist Manager
Guizhou Xinbang Pharmaceutical Co Ltd Logo
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Watchlist
Price: 3.89 CNY -1.27% Market Closed
Updated: May 18, 2024

Guizhou Xinbang Pharmaceutical Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guizhou Xinbang Pharmaceutical Co Ltd
Cost of Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Cost of Revenue
-¥5.3B
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
-37%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cost of Revenue
-¥1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cost of Revenue
-¥5.7B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cost of Revenue
-¥3.8B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cost of Revenue
-¥28.9B
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cost of Revenue
-¥242.3m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Guizhou Xinbang Pharmaceutical Co Ltd's Cost of Revenue?
Cost of Revenue
-5.3B CNY

Based on the financial report for Mar 31, 2024, Guizhou Xinbang Pharmaceutical Co Ltd's Cost of Revenue amounts to -5.3B CNY.

What is Guizhou Xinbang Pharmaceutical Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-37%

Over the last year, the Cost of Revenue growth was -1%. The average annual Cost of Revenue growth rates for Guizhou Xinbang Pharmaceutical Co Ltd have been -4% over the past three years , and -37% over the past ten years .